Efficacy and safety of PD-1 inhibitors combined with anti-angiogenic agents in patients with recurrent or metastatic nasopharyngeal carcinoma: a systematic review and meta-analysis
{{output}}
Objectives: PD-1 inhibitors have shown significant progress in treating recurrent or metastatic nasopharyngeal carcinoma (R/M NPC); however, the optimal second-line regimen remains unclear. Studies have suggested that the combina... ...
